Rolf Mertens
About
In The Last Decade
Rolf Mertens
16 papers receiving 362 citations
Peers
Comparison fields: 5 of 60
- Otorhinolaryngology 144
- Oncology 138
- Surgery 132
- Molecular Biology 97
- Pulmonary and Respiratory Medicine 81
Countries citing papers authored by Rolf Mertens
This map shows the geographic impact of Rolf Mertens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Mertens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Mertens more than expected).
Fields of papers citing papers by Rolf Mertens
This network shows the impact of papers produced by Rolf Mertens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Mertens. The network helps show where Rolf Mertens may publish in the future.
Co-authorship network of co-authors of Rolf Mertens
This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Mertens. A scholar is included among the top collaborators of Rolf Mertens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Mertens. Rolf Mertens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 22 | |
| 3 | Identification by high-throughput in silico screening of radio-protecting compounds targeting the DNA-binding domain of the tumor suppressor p53. | 7 |
| 4 | 20 | |
| 5 | 55 | |
| 6 | 75 | |
| 7 | 4 | |
| 8 | 73 | |
| 9 | 13 | |
| 10 | 8 | |
| 11 | Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors. | 4 |
| 12 | 1 | |
| 13 | 6 | |
| 14 | 51 | |
| 15 | 19 | |
| 16 | Bisherige Erfahrungen der Interferontherapie an 7 Patienten mit Nasopharynxkarzinom | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.